Latest Breaking News On - Katherinel ruffner - Page 1 : comparemela.com

Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

United statesHeinz josef lenzActa oncologicaMark erlanderAmy jobeVicki kelemenJoyce allaireKatherinel ruffnerCardiff oncology incInova schar cancer instituteCancer centerPrnewswire cardiff oncology incExchange commissionKansas university medical centerLifesci communicationsNorris comprehensive cancer center

Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

United statesHeinz josef lenzActa oncologicaMark erlanderAmy jobeVicki kelemenJoyce allaireKatherinel ruffnerCardiff oncology incInova schar cancer instituteCancer centerPrnewswire cardiff oncology incExchange commissionKansas university medical centerLifesci communicationsNorris comprehensive cancer center

Why Shares of Cardiff Oncology Rose on Monday

Why Shares of Cardiff Oncology Rose on Monday
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United statesJamese levineKatherinel ruffnerAmerican cancer societyChief medical officer katherineஒன்றுபட்டது மாநிலங்களில்அமெரிக்கன் புற்றுநோய் சமூகம்

Cardiff Oncology Announces New Data from Phase 1b/2 Trial in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival

Cardiff Oncology Announces New Data from Phase 1b/2 Trial in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesCity of hopeHeinz josef lenzActa oncologicaAmy jobeAfsaneh barziJoyce allaireKatherinel ruffnerMark erlanderVicki kelemenCardiff oncology incInova schar cancer instituteCancer centerExchange commissionLifesci communicationsKansas university

Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates

Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHeinz josef lenzActa oncologicaReneep tannenbaumDanielh ahnMani mohindruAmy jobeJoyce allaireAfsaneh barziManishr sharmaKatherinel ruffnerJamese levineMark erlanderVicki kelemenCardiff oncology incPdac program